Articles
- Details
- Published on Wednesday, 22 September 2010 12:50
- Hits: 2026
JCI Editorials/Perspectives/Commentaries 2009
| ISSUE | PERSPECTIVES/COMMENTARIES |
| January 2009 |
Predicting response to hepatitis C therapy *
Revisiting Notch in remyelination of multiple sclerosis lesions *
CD4+ T cells mediate cytotoxicity in neurodegenerative diseases *
Deciphering migraine *
|
| February 2009 |
Glucocorticoids and neonatal brain injury: the hedgehog connection *
Hoofbeats, zebras, and insights into insulin resistance *
|
| March 2009 |
All data are not created equal
|
| April 2009 |
Preventing and exploiting the oncogenic potential of integrating gene vectors *
Wnt therapy for bone loss: golden goose or Trojan horse? *
Can licorice lick colon cancer? *
The voltage-gated K+ channel subunit Kv1.1 links kidney and brain *
Myoglobin tames tumor growth and spread *
Kallikreins and lupus nephritis *
|
| May 2009 |
FGFR3-targeted mAb therapy for bladder cancer and multiple myeloma *
Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed *
CaMKII and a failing strategy for growth in heart *
Genetic susceptibility to HIV-associated nephropathy *
|
| June 2009 |
Reinvestment and recovery
|
| July 2009 |
Treating MS: getting to know the two birds in the bush *
Restraining order for dendritic cells: all quiet on the fetal front *
|
3 August 2009 Vol.119;8 |
Commentaries(1)MicroRNA reexpression as differentiation therapy in cancer(2)Genomic amplicons target vesicle recycling in breast cancer(3)Anticancer immunochemotherapy using adjuvants with direct cytotoxic effects(4)Reduced levels of neurotransmitter-degrading enzyme PRCP promote obesity(5)Enaging the lysosomal compartment to combat B cell malignancies(6)EBAG9 tempers lymphocyte killing activity(7)Haptoglobin halts hemoglobin's havoc |
| 1 September 2009 Vol.119;9 |
Commentaries(1)MicroRNA-modulated targeting of vascular smooth cells(2)Defining a role for the homeprotein Six1 in EMT and mammary tumorignesis(3)Endocytic control of ion channel density as a target for cardiovascular disease(4)Pass the bicarb: the importance of HCO3–for mucin release |
| 1 October 2009 Vol.119;10 |
Commentaries(1)NF-kB2(p100) limitsTNF-α--induced osteoclastogenesis(2)Pathogenic antibodies are active participants in spinal cord injury(3)Reduced thymus activity and infection prematurely age the immune system(4)Pin 1 regulates parathyroid hormone mRNA stability(5)Resolving lung injury: a new role for Tregs in controlling the innate immune response (6)Breast cancer gene variants: separating the harmful from the harmless |
| 1 November 2009 Vol.119;11 |
Commentaries(1)Homocysteine-mediated thrombosis and angiostasis in vascular pathobiology(2)The APCs of neuroprotection(3)Smad4: gatekeeper gene in head and neck squamous cell carcinoma |
| 1 December 2009 Vol.119;12 |
Commentaries(1)Resolution of immune activation defines nonpathogenic SIV infection(2)Phosducin--a candidate gene for stress-dependent hypertension
|